je.st
news
UPDATE 2-J&J beats forecasts, helped by new hepatitis C drug
2014-07-15 19:05:54| Food - Topix.net
Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. Olysio, which U.S. regulators approved in November, chalked up sales of $831 million for the second quarter and $1.19 billion for the year to date.
Tags: update
drug
helped
beats
Category:Food and Related Products